Based on early trials, the advised antiplatelet regimen for drug-eluting stents was a combination of aspirin and clopidogrel for 3 months when Cypher stents were used, and 9 months when Taxus stents were used, followed by aspirin indefinitely.
Following initial clinical trials, the advised treatment plan for patients with drug-eluting stents included a regimen of antiplatelet medication that lasted from 3 to 9 months, depending on the specific stent used, after which patients were recommended to take aspirin indefinitely.